Skip to content
healthcare.dev

VYVGART Hytrulo

NDC 73475-1221, efgartigimod alfa and hyaluronidase (human recombinant), injection, solution, from argenx US.

Product NDC
73475-1221
Status
Listed
Labeler
argenx US
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761304
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73475-1221 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFGARTIGIMOD ALFA200 mg/mL
  • HYALURONIDASE (HUMAN RECOMBINANT)2000 U/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Neonatal Fc Receptor Blocker [EPC]; Neonatal Fc Receptor Blockers [MoA]

Package NDCNDC-11Package
73475-1221-1734751221011 SYRINGE, GLASS in 1 CARTON (73475-1221-1) / 5 mL in 1 SYRINGE, GLASS
73475-1221-4734751221044 SYRINGE, GLASS in 1 CARTON (73475-1221-4) / 5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7104d9e5-9910-47f5-9a93-741ac50f43b6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=73475-1221

Use it

Look up 73475-1221 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73475-1221 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73475-1221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.